SEC Form 4 · accession 0001209191-19-002038
SURMODICS INC · SRDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary R Maharaj
Officer — President & CEO · Director
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000924717
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 2, 2019 | S | 4,900 | $46.2045 | D | 174,967 | D | |
| Common Stock | Jan 2, 2019 | S | 100 | $46.83 | D | 174,867 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
- F2Reflects the weighted average price of 4,900 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on January 2, 2019 with sale prices ranging from $45.76 to $46.67 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.